Most articles on choosing a CRO partner tell you the same thing. Look for experience. Check regulatory expertise. Ask about quality systems. This advice is not necessarily wrong, but it is not very useful either. Almost every CRO company will claim to tick these boxes on their website. The real problem is different. Sponsors usually know what to look for. What they don’t have […]
If your pharma company is planning its first trial, or bringing in a new team to run one, you have probably heard people throw around terms like “Phase II” or “Phase III” in meetings. It can feel like everyone else already knows what this mean, and you are the only one guessing. In this blog, we have broken down clinical […]
A Clinical Study Report (CSR) is one of the most important documents in drug development. It summarises the results of a clinical trial for regulatory agencies like the FDA and EMA. Getting it right matters. Even minor errors can trigger lengthy reviewer queries. In serious cases, they can lead to rejection or a Complete Response […]
Modern drug development is becoming increasingly complex. Clinical studies now span multiple countries, patient recruitment is more competitive, and regulatory requirements continue to evolve. According to the Tufts Center for the Study of Drug Development, bringing a new drug to market can take over a decade and cost more than $2.6 billion, making efficient clinical execution critical for […]
